700PSTAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer
| dc.contributor.author | Kocher, HM | en_US |
| dc.contributor.author | Basu, B | en_US |
| dc.contributor.author | Froeling, FEM | en_US |
| dc.contributor.author | Sarker, D | en_US |
| dc.contributor.author | Slater, S | en_US |
| dc.contributor.author | Carlin, D | en_US |
| dc.contributor.author | Coetzee, C | en_US |
| dc.contributor.author | de Souza, N | en_US |
| dc.contributor.author | Goulart, M | en_US |
| dc.contributor.author | Hughes, C | en_US |
| dc.contributor.author | Imrali, A | en_US |
| dc.contributor.author | Lawrence, C | en_US |
| dc.contributor.author | Mousa, K | en_US |
| dc.contributor.author | North, B | en_US |
| dc.contributor.author | Prendergast, A | en_US |
| dc.contributor.author | Roberts, R | en_US |
| dc.contributor.author | Sasieni, P | en_US |
| dc.contributor.author | Propper, D | en_US |
| dc.date.accessioned | 2020-10-12T13:06:38Z | |
| dc.date.issued | 2019-10-01 | en_US |
| dc.identifier.issn | 0923-7534 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67508 | |
| dc.format.extent | v267 - ? | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.title | 700PSTAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1093/annonc/mdz247.027 | en_US |
| pubs.issue | Supplement_5 | en_US |
| pubs.notes | Not known | en_US |
| pubs.volume | 30 | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
